Gregory Bonfiglio

Proteus RM invests in companies located in the United States. The firm focuses on regenerative medicine, cell therapy, gene therapy, tissue engineering, bio-asethic medicine and underpinning technologies sectors. It provides financing for early stage capital requirements.

The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content.

Conducts cell-based research, processing, and manipulation, and publishes researched materials

Develops human therapies based on human embryonic stem cells

Develops allogeneic immunotherapies for cancer

Develops embryonic stem cells for drug discovery and development

Sells gift baskets via the Internet

Anthem Venture Management invests in companies located in the United States primarily in Southern California. The firm focuses on the technology sector. It participates in early stage capital requirements with an investment size of USD 1 –5 million and also makes co-investments. It acts as lead or co-lead investor and takes a seat on the board of directors.